We are a unique global health partnership
Developing synergistic approaches for prevention and control
GDAC advises and provides consultation to national and local health agencies in the development and implementation of innovative, targeted and synergistic approaches to prevent and control Aedes-transmitted diseases including dengue, Zika, chikungunya and yellow fever.
Our goals are in line with the WHO global strategy and include accelerating innovations in vaccines, therapeutics, vector control, disease surveillance and diagnostics; promoting evidence-based prevention and control strategies nationally and internationally; strengthening advocacy, capacity building and networking.
Over the last few decades, diseases transmitted by the Aedes mosquito have spread rapidly around the world. More than half of the world’s population live in areas where the Aedes mosquito species is present.
News & Events
January 6, 2023 - Singapore
Butantan's dengue vaccine has 79.6% efficacy, partial results from 2-year follow-up
January 2, 2023 - Singapore
Takeda’s QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union
January 20-22, 2020 - Les Pensières Center for Global Health, Veyrier-du-Lac (France)
Dengue pre-vaccination screening strategies workshop